20.14.Z - Manufacture of other organic basic chemicals
10.89.Z - Production of other food products, not elsewhere classified
20.42.Z - Manufacture of cosmetics and toilet preparations
20.53.Z - Manufacture of chemicals and chemical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.39.Z - Wholesale trade of non-specialized food, beverages, and tobacco products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
47.91.Z - Intermediary retail sale, non-specialized
72.19.Z - Scientific research and development activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 201 | -35 | 64,6 | 284,7 |
EBITDA | 206 | -36,6 | 100,1 | 373,4 |
Short time liabilities | 19,3 | 269,9 | 232,8 | -13,8 |
Equity capital | 311,5 | 272,9 | 331,6 | 21,5 |
Operating profit (EBIT) | 206 | -36,6 | 100,1 | 373,4 |
Assets | 330,8 | 962 | 983,6 | 2,2 |
Net profit (loss) | 188,5 | -38,6 | 58,6 | 252 |
Cash | 163,7 | 44,7 | 135,7 | 203,2 |
Liabilities and provisions for liabilities | 19,3 | 689,1 | 652 | -5,4 |
Net income from sale | 517 | 513,6 | 414,4 | -19,3 |
Working assets | 330,8 | 657 | 678,6 | 3,3 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 60,5 | -14,1 | 17,7 | 31,8 |
Equity capital to total assets | 94,2 | 28,4 | 33,7 | 5,3 |
Gross profit margin | 38,9 | -6,8 | 15,6 | 22,4 |
EBITDA Margin | 39,9 | -7,1 | 24,2 | 31,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 14 | 192 | 205 | 13 |
Current financial liquidity indicator | 17.1063175201416 | 2.4342074394226074 | 2.9149010181427 | 0,5 |
Net dept to EBITDA | -0.7944778203964233 | -10.225439071655273 | 2.831796884536743 | 13 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane